Compare Two Different Sclerosing Agents in the Treatment of Venous Malformations

PHASE4Active, not recruitingINTERVENTIONAL

Enrollment

135

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

November 30, 2023

Study Completion Date

June 30, 2025

Conditions

Venous Malformation

Interventions

DRUG

Bleomycin

Intralesional

DRUG

Fibrovein

Intralesional

DRUG

Bleomycin + Fibrovein

Intralesional

Trial Locations (1)

Oslo Universitetssykehus Rikshospitalet, Oslo

All Listed Sponsors

lead

Oslo University Hospital

OTHER